1. Structured exercise post-chemotherapy benefits colorectal cancer survivors with improved survival outcomes and reduced cancer recurrences.
2. Exercise group had a 28% lower risk of disease recurrence compared to the control group.
3. Five-year disease-free survival was 80.3% in the exercise group.
4. Adverse events linked to exercise were reported in both groups, albeit modest.
5. Median baseline age was 61 years with a majority receiving FOLFOX chemotherapy.
6. The trial's findings support the potential of structured exercise to enhance long-term outcomes in colorectal cancer survivors.

Source: The New England Journal of Medicine